A Randomised Phase II Study of Pegylated Liposomal Doxorubicine in Elderly Patients with Acute Lymphoblastic Leukemia (ALL): The GRAALL-SA1 Study

被引：0

作者：

Hunault-Berger, Mathilde

Leguay, Thibaut ^{[1
]}

Thomas, Xavier ^{[2
]}

Legrand, Ollivier ^{[3
]}

Huguet, Francoise ^{[4
]}

Witz, Francis ^{[5
]}

Escoffre-Barbe, Martine ^{[6
]}

Legros, Laurence ^{[7
]}

Turlure, Pascal ^{[8
]}

Chevallier, Patrice ^{[9
]}

Larosa, Fabrice ^{[10
]}

Cahn, Jean-Yves

Reman, Oumedaly ^{[11
]}

Rousselot, Philippe ^{[12
,13
]}

Delannoy, Andre ^{[14
]}

Dhedin, Nathalie ^{[15
]}

Pochitaloff, Marina ^{[16
]}

Bene, Marie-Christine

Ifrah, Norbert ^{[17
]}

Dombret, Herve ^{[18
]}

机构：

[1] CH Bordeaux, Bordeaux, France

[2] GRAAL Grp, Lyon, France

[3] Hop Hotel Dieu, F-75181 Paris, France

[4] CHU Toulouse, Toulouse, France

[5] Hop Brabois, Nancy, France

[6] Hop Pontchaillou, Hematol Clin, Rennes, France

[7] CHU Nice, Nice, France

[8] CHU Limoges, Limoges, France

[9] CHU Hotel Dieu, Nantes, France

[10] CHU Jean Minjoz, INSERM, UMR645, Besancon, France

[11] CHU Caen, F-14000 Caen, France

[12] Hop Mignot, Versailles, France

[13] CIC9504, Versailles, France

[14] Hop Jolimont, Haine St Paul, Belgium

[15] Hop La Pitie Salpetriere, Serv Hematol Clin, Paris, France

[16] Cytogenet, Marseille, France

[17] CHU Angers, Serv Malad Sang, Angers, France

[18] Hop St Louis, AP HP, Paris, France

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：340 / 340

页数：1

共 50 条

[41] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia
O G Ottmann
R A Larson
H M Kantarjian
P D le Coutre
M Baccarani
A Hochhaus
D W Kim
X Fan
S Novick
F J Giles
Leukemia, 2013, 27 : 1411 - 1413
[42] Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study
A Delannoy
E Delabesse
V Lhéritier
S Castaigne
F Rigal-Huguet
E Raffoux
F Garban
O Legrand
S Bologna
V Dubruille
P Turlure
O Reman
M Delain
F Isnard
D Coso
P Raby
A Buzyn
S Caillères
S Darre
C Fohrer
A Sonet
C Bilhou-Nabera
M-C Béné
H Dombret
P Berthaud
X Thomas
Leukemia, 2006, 20 : 1526 - 1532
[43] A Phase II Study of Midostaurin and 5-Azacitidine for Elderly Patients with Acute Myeloid Leukemia
Gallogly, Molly M.
Tomlinson, Ben K.
Bunner, Pam
Caimi, Paolo
Craig, Michael
de Lima, Marcos
Gerson, Stanton L.
Kane, Donna
Lazarus, Hillard M.
Levis, Mark J.
Malek, Ehsan
Little, Jane A.
Street, Crystal
van Heeckeren, Willem J.
Tse, William
Cooper, Brenda W.
BLOOD, 2017, 130
[44] Prevention of Venous Thrombotic Events in Adult Patients with Acute Lymphoblastic Leukemia Treated in a Pediatric-Inspired Protocol - a Graall Study
Orvain, Corentin
Balsat, Marie
Lheritier, Veronique
Tavernier, Emmanuelle
Marolleau, Jean-Pierre
Pabst, Thomas
Chevallier, Patrice
De Gunzburg, Noemie
Cacheux, Victoria
Huguet, Francoise
Chantepie, Sylvain
Caillot, Denis
Chalandon, Yves
Frayfer, Jamile
Bonmati, Caroline
Boissel, Nicolas
Dombret, Herve
Ifrah, Norbert
Hunault-Berger, Mathilde
BLOOD, 2016, 128 (22)
[45] Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
Koh, Katsuyoshi
Ogawa, Chitose
Okamoto, Yasuhiro
Kudo, Kazuko
Inagaki, Jiro
Morimoto, Tsuyoshi
Mizukami, Hideya
Ecstein-Fraisse, Evelyne
Kikuta, Atsushi
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (02) : 245 - 255
[46] Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
Katsuyoshi Koh
Chitose Ogawa
Yasuhiro Okamoto
Kazuko Kudo
Jiro Inagaki
Tsuyoshi Morimoto
Hideya Mizukami
Evelyne Ecstein-Fraisse
Atsushi Kikuta
International Journal of Hematology, 2016, 104 : 245 - 255
[47] Phase II study of combination of hyperCVAD with ponatinib in frontline therapy of patients (pts) with Philadelphia chromosome (Ph) positive acute lymphoblastic leukemia (ALL).
O'Brien, Susan Mary
Jabbour, Elias
Thomas, Deborah A.
Ravandi, Farhad
Cortes, Jorge E.
Pemmaraju, Naveen
Kadia, Tapan M.
Garris, Rebecca
Jeanis, Vicky
Garcia-Manero, Guillermo
Borthakur, Gautam
Wierda, William G.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[48] Phase II study of combination of hyperCVAD with ponatinib in frontline therapy of patients (pts) with Philadelphia chromosome (Ph) positive acute lymphoblastic leukemia (ALL).
Jabbour, Elias
Kantarjian, Hagop M.
Thomas, Deborah A.
Ravandi, Farhad
Cortes, Jorge E.
Faderl, Stefan
Pemmaraju, Naveen
Kadia, Tapan M.
Garris, Rebecca S.
Garcia-Manero, Guillermo
Borthakur, Gautam
Wierda, William G.
O'Brien, Susan Mary
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[49] Phase II study of hyper-CVAD followed by nelarabine consolidation in newly diagnosed patients with T cell acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LL).
Vigil, C. E.
Kantarjian, H.
Thomas, D. A.
O'Brien, S. M.
Kashani, F. Ravandi
Koller, C. A.
Burger, J. A.
Garris, R. S.
Baccus, M. D.
Faderl, S.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[50] Phase II Study of Nelarabine with Hyper-CVAD in Patients with Previously Untreated T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (LL)
Jain, Preetesh
Kantarjian, Hagop M.
Thomas, Deborah A.
Ravandi, Farhad
Kadia, Tapan M.
Burger, Jan A.
Borthakur, Gautam
Cortes, Jorge E.
Daver, Naval
Jabbour, Elias J.
Koller, Charles Asa
Konopleva, Marina
Pemmaraju, Naveen
Kelly, Marry A.
Garris, Rebecca
O'Brien, Susan
Faderl, Stefan
BLOOD, 2012, 120 (21)

← 1 2 3 4 5 →